Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SNORA29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MRPL18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129518 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNLDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WTAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGF2R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on